Artia Global Partners LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001937964

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2025 · 50 positions · Total reported value $455.04M · Top-10 concentration 70.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 13 new · 4 cut · 10 exited

Active Share (vs S&P 500): 98.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.6% · Prev Value $541.86M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.4% · Latest Value $495.64M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Artia Global Partners LP disclosed 50 equity positions with a combined reported value of $455.04M. The filing implies a focused portfolio: its ten largest positions account for 70.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were INSM ($73.10M), ARGX ($54.41M), LLY ($54.27M). By sector, the heaviest allocations are Health Care 89.2%, Industrials 3.1%. Versus the prior quarter, allocation shifted toward Health Care (+19.5pp), Industrials (+1.4pp) and away from Other (-20.6pp).

Versus the prior quarter, Artia Global Partners LP opened 13 new positions, trimmed 4 and fully exited 10, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 46% of names.

The largest new positions opened in Q4 2025 were CDTX ($15.64M), VTYX ($6.28M), PVLA ($6.20M).

Of the 10 positions fully exited versus the prior quarter, the largest were VRNA ($40.44M), MRUS ($27.94M), VRTX ($21.58M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • CDTX CIDARA THERAPEUTICS INC · $15.64M
  • VTYX VENTYX BIOSCIENCES INC · $6.28M
  • PVLA PALVELLA THERAPEUTICS INC NE · $6.20M
  • SION SIONNA THERAPEUTICS INC · $4.93M
  • PALI PALISADE BIO INC · $4.68M
  • PROK PROKIDNEY CORP · $4.12M
  • BLTE BELITE BIO INC · $2.88M
  • ROIV ROIVANT SCIENCES LTD · $2.82M

Fully Exited (vs previous quarter)

  • VRNA VERONA PHARMA PLC · prev qtr: $40.44M
  • MRUS MERUS N V · prev qtr: $27.94M
  • VRTX VERTEX PHARMACEUTICALS INC · prev qtr: $21.58M
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $17.89M
  • REGN REGENERON PHARMACEUTICALS · prev qtr: $6.00M
  • NKTR NEKTAR THERAPEUTICS · prev qtr: $3.30M
  • CNTA CENTESSA PHARMACEUTICALS PLC · prev qtr: $3.23M
  • TGTX TG THERAPEUTICS INC · prev qtr: $1.97M

Insider Transactions (Form 4)

Latest Artia Global Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Artia Global Partners LP is an SEC-registered 13F filer based in Miami, FL, United States. As of Q2 2026 it reported 48 US equity positions with a combined value of $541.86M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MIAMI, FL, United States
  • SEC registration: 801-125942 (status: Approved), registered 2022-06-23
  • Regulatory AUM (Form ADV): $778.89M as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 48 positions · $541.86M reported value (Q2 2026)
  • Top 10 holdings = 64.5% of reported value
  • Largest position: ABVX (ABIVAX SA) at 12.7%
  • Average position size: $11.29M

Sector Tilt

  • Health Care 94.9%
  • Industrials 2.0%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 7 new, 11 added, 2 reduced, 8 exited
  • 28 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 89.2%
Other 7.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 420.00K $73.10M 16.06%
16.06%
Add
2 64.70K $54.41M 11.96%
11.96%
Reduce
3 50.50K $54.27M 11.93%
11.93%
Add
4 719.37K $25.31M 5.56%
5.56%
Add
5 2.01M $25.21M 5.54%
5.54%
Add
6 1.02M $24.49M 5.38%
5.38%
Add
7 503.94K $17.68M 3.88%
3.88%
Add
8 190.75K $17.54M 3.85%
3.85%
Hold
9 70.82K $15.64M 3.44%
3.44%
New
10 767.10K $14.01M 3.08%
3.08%
Add
11 144.38K $11.42M 2.51%
2.51%
Add
12 205.09K $8.45M 1.86%
1.86%
Add
13 104.19K $8.30M 1.82%
1.82%
Hold
14 40.82K $7.08M 1.56%
1.56%
Reduce
15 17.40K $6.92M 1.52%
1.52%
Reduce
16 695.98K $6.28M 1.38%
1.38%
New
17 59.20K $6.20M 1.36%
1.36%
New
18 100.00K $5.55M 1.22%
1.22%
Reduce
19 137.80K $5.00M 1.10%
1.10%
Add
20 119.74K $4.93M 1.08%
1.08%
New
21 1.99M $4.68M 1.03%
1.03%
New
22 60.10K $4.34M 0.95%
0.95%
Reduce
23 96.28K $4.24M 0.93%
0.93%
Hold
24 138.51K $4.20M 0.92%
0.92%
Add
25 1.84M $4.12M 0.91%
0.91%
New
26 17.74K $3.78M 0.83%
0.83%
Add
27 14.50K $3.31M 0.73%
0.73%
Hold
28 17.99K $2.88M 0.63%
0.63%
New
29 129.80K $2.82M 0.62%
0.62%
New
30 70.70K $2.70M 0.59%
0.59%
Add
31 33.41K $2.61M 0.57%
0.57%
New
32 5.00K $2.44M 0.54%
0.54%
Hold
33 50.00K $2.31M 0.51%
0.51%
Reduce
34 22.95K $2.00M 0.44%
0.44%
Hold
35 68.65K $1.86M 0.41%
0.41%
New
36 40.00K $1.79M 0.39%
0.39%
Hold
37 20.40K $1.56M 0.34%
0.34%
Hold
38 41.60K $1.56M 0.34%
0.34%
Hold
39 205.32K $1.34M 0.29%
0.29%
New
40 9.90K $1.34M 0.29%
0.29%
Reduce
41 12.90K $1.29M 0.28%
0.28%
New
42 29.20K $1.20M 0.27%
0.27%
Hold
43 85.20K $1.03M 0.23%
0.23%
Reduce
44 8.10K $814.78K 0.18%
0.18%
New
45 41.57K $754.91K 0.17%
0.17%
New
46 2.50K $736.85K 0.16%
0.16%
New
47 29.19K $519.62K 0.11%
0.11%
New
48 42.08K $512.96K 0.11%
0.11%
New
49 17.02K $475.85K 0.10%
0.10%
New
50 8.76K $26.97K 0.01%
0.01%
New

FAQ

What did Artia Global Partners LP buy in 2025-Q4?

In its 2025-Q4 13F filing, Artia Global Partners LP reported 50 equity positions worth $455.04M in aggregate; its largest disclosed positions were INSM ($73.10M), ARGX ($54.41M), LLY ($54.27M).

How large is Artia Global Partners LP's portfolio?

Artia Global Partners LP reported $455.04M of long equity holdings across 50 positions as of 2025-Q4. Top-10 holdings account for 70.7% of reported value.

What is Artia Global Partners LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/artia-global-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →